1Hariprasad S M,Mieler W F,Holz E R,et al.Determination of vitreous,aqueous,and plasma concentration of orally administered voriconazole in humans[J].Arch Ophthalmol,2004,122(1):42-47.
2Kalavathy C M,Parmar P,Kaliamurthy J,et al.Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis[J].Comea,2005,24(4):449-452.
3Marangon F B,Miller D,Giaconi J A,et al.In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens[J].Am J Ophthalmol,2004,137(5):820-825.
4Prajna N V,Nirmalan P K,Mahalakshmi R,et al.Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis[J].Comea,2004,23 (8):793-796.
5Xie L,Zhong W,Shi W,et al.Spectrum of fungal keratitis in north China[J].Ophthalmology,2006,113(11):1943-1948.
6Thomas P A.Current perspectives on ophthalmic mycoses[J].Clin Microbiol Rev,2003,16(4):730-797.
